Paper42540554
Serum metabolomic profiling identifies a biomarker panel associated with age-related hearing loss.
Wang H and 4 others. Biochem Biophys Rep, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Serum metabolomic profiling identifies a biomarker panel associated with age-related hearing loss. Papers, record 42540554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42540554
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum metabolomic profiling identifies a biomarker panel associated with age-related hearing loss.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36908822 | METTL3-mediated m6A modification of has_circ_0007905 promotes age-related cataract progression through miR-6749-3p/EIF4EBP1. | PeerJ | 2023 | https://conductscience.org/library/papers/36908822 | PubMed |
| 2 | 36289355 | Relevance of plasma biomarkers to pathologies in Alzheimer's disease, Parkinson's disease and frontotemporal dementia. | Sci Rep | 2022 | https://conductscience.org/library/papers/36289355 | PubMed |
| 3 | 36788598 | Asymmetric dysregulation of glutamate dynamics across the synaptic cleft in a mouse model of Alzheimer's disease. | Acta Neuropathol Commun | 2023 | https://conductscience.org/library/papers/36788598 | PubMed |
| 4 | 40744899 | The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system. | Brain Pathol | 2026 | https://conductscience.org/library/papers/40744899 | PubMed |
| 5 | 39411148 | Age-related hearing loss in older adults: etiology and rehabilitation strategies. | Front Neurosci | 2024 | https://conductscience.org/library/papers/39411148 | PubMed |
| 6 | 39067415 | A new mutation of Sgms1 causes gradual hearing loss associated with a reduced endocochlear potential. | Hear Res | 2024 | https://conductscience.org/library/papers/39067415 | PubMed |
| 7 | 25356849 | Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss. | PLoS Genet | 2014 | https://conductscience.org/library/papers/25356849 | PubMed |
| 8 | 36143200 | The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases. | J Pers Med | 2022 | https://conductscience.org/library/papers/36143200 | PubMed |
| 9 | 41630328 | Genetically predicted cerebrospinal fluid metabolite levels and risk of sudden sensorineural hearing loss: A Mendelian randomization study. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41630328 | PubMed |
| 10 | 39976059 | Gamma-aminobutyric acid and glutamate/glutamine associations with tinnitus and hearing loss. | Neuroreport | 2025 | https://conductscience.org/library/papers/39976059 | PubMed |
| 11 | 38687845 | Clinical Practice Guideline: Age-Related Hearing Loss. | Otolaryngol Head Neck Surg | 2024 | https://conductscience.org/library/papers/38687845 | PubMed |
| 12 | 31985279 | L-glutamine for sickle cell disease: Knight or pawn? | Exp Biol Med (Maywood) | 2020 | https://conductscience.org/library/papers/31985279 | PubMed |
| 13 | 38482977 | A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease. | Basic Clin Pharmacol Toxicol | 2024 | https://conductscience.org/library/papers/38482977 | PubMed |
| 14 | 34335635 | NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34335635 | PubMed |
| 15 | 27383011 | S1PR2 variants associated with auditory function in humans and endocochlear potential decline in mouse. | Sci Rep | 2016 | https://conductscience.org/library/papers/27383011 | PubMed |
| 16 | 39683904 | Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer's Disease, a Potential Therapeutic Target. | Molecules | 2024 | https://conductscience.org/library/papers/39683904 | PubMed |
| 17 | 34533433 | The World Health Organization (WHO) hearing impairment guidelines and a speech recognition in noise (SRN) disorder. | Int J Audiol | 2022 | https://conductscience.org/library/papers/34533433 | PubMed |
| 18 | 37394885 | m 6A methylation in cellular senescence of age-associated diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | https://conductscience.org/library/papers/37394885 | PubMed |
| 19 | 38161109 | The genetic landscape of age-related hearing loss. | Trends Genet | 2024 | https://conductscience.org/library/papers/38161109 | PubMed |
| 20 | 40453791 | Age-Related Hearing Loss: Evidence-Based Strategies for Early Detection and Management. | ORL Head Neck Nurs | 2025 | https://conductscience.org/library/papers/40453791 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42540554
GET https://conductscience.org/api/papers/v1/42540554/references?page=2